Veterans’ RightsAn independent resource for veterans
← All decisions
Remanded (sent back)

The Board has remanded the case for further development due to additional evidence received and to determine if the Veteran was exposed to herbicides during service in Thailand and Korea.

The deciding factor: Further development is necessary to verify the Veteran's exposure to herbicides during his service in Thailand and Korea.

Claimed conditions
diabetes mellitus, peripheral neuropathy of bilateral upper extremities, peripheral neuropathy of bilateral lower extremities
How they argued it
Presumptive (no nexus needed)
Exposure basis
Gulf War
Rating assigned
None in this decision
Decision date
April 19, 2013
Citation
1313170

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1313170.

What this means for you

A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.